8-Methoxypsoralen plus UVA treatment increases the proportion of CLA+CD25+CD4+ T cells in lymph nodes of K5.hTGFβ1 transgenic mice

Experimental Dermatology

Volumn 21, Issue 3, 2012, Pages 228-230

  Singh, Tej Pratap ^a   Schön, Michael P ^b   Wallbrecht, Katrin ^b   Wolf, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cutaneous lymphocyte associated antigen; Psoralen; Psoriasis; T cell homing; UVA

Indexed keywords

CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; METHOXSALEN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; LETTER; LYMPH NODE; MOUSE; NONHUMAN; PHOTOCHEMOTHERAPY; REGULATORY T LYMPHOCYTE; ULTRAVIOLET A RADIATION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DISEASE MODELS, ANIMAL; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; METHOXSALEN; MICE; MICE, TRANSGENIC; PHOTOSENSITIZING AGENTS; PSORIASIS; PUVA THERAPY; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84857745483     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01437.x     Document Type: Letter

References (33)

1. Knibbs R N, Craig R A, Natsuka S et al. J Cell Biol 1996: 133: 911-920.
2. Wagers A J, Kansas G S. J Immunol 2000: 165: 5011-5016.
3. Lim Y C, Henault L, Wagers A J et al. J Immunol 1999: 162: 3193-3201.
4. Picker L J, Treer J R, Fergusondarnell B et al. J Immunol 1993: 150: 1122-1136.
5. Sigmundsdottir H, Johnston A, Gudjonsson J E et al. Clin Immunol 2004: 111: 119-125.
6. Bos J D, Deboer O J, Tibosch E et al. Arch Dermatol Res 1993: 285: 179-183.
7. Picker L J, Kishimoto T K, Smith C W et al. Nature 1991: 349: 796-799.
8. Campbell J J, Murphy K E, Kunkel E J et al. J Immunol 2001: 166: 877-884.
9. Schwarz A, Maeda A, Wild M K et al. J Immunol 2004: 172: 1036-1043.
10. Singh T P, Schön M P, Wallbrecht K et al. J Immunol 2010: 184: 7257-7267.
11. Michaelis K, Wallbrecht K, Kerstan A et al. Exp Dermatol 2010: 19: 406-415.
12. Singh T P, Huettner B, Koefeler H et al. Am J Pathol 2011: 178: 699-708.
13. Zibert J R, Wallbrecht K, Schön M et al. J Clin Invest 2011: 121: 410-421.
14. Wolf P, Nghiem D X, Walterscheid J P et al. Am J Pathol 2006: 169: 795-805.
15. Tomura M, Honda T, Tanizaki H et al. J Clin Invest 2010: 120: 883-893.
16. Furuhashi T, Torii K, Kato H et al. Exp Dermatol 2011: 20: 768-770.
17. Wolf P, Byrne S N, Gruber-Wackernagel A. Exp Dermatol 2009: 18: 350-356.
18. Gruber-Wackernagel A, Byrne S N, Wolf P. Front Biosci (Elite Ed) 2009: 1: 341-354.
19. Beissert S, Schwarz A, Schwarz T. J Invest Dermatol 2006: 126: 15-24.
20. Heid J B, Schmidt A, Oberle N et al. J Invest Dermatol 2009: 129: 2875-2885.
21. Kim E J, Hess S, Richardson S K et al. J Clin Invest 2005: 115: 798-812.
22. Tiemessen M M, Mitchell T J, Hendry L et al. J Invest Dermatol 2006: 126: 2217-2223.
23. Knol A C, Quereux G, Brocard A et al. Exp Dermatol 2010: 19: e95-e102.
24. Maeda A, Schwarz A, Kernebeck K et al. J Immunol 2005: 174: 5968-5976.
25. Meloni F, Cascina A, Miserere S et al. Transplant Proc 2007: 39: 213-217.
26. Maeda A, Schwarz A, Bullinger A et al. J Immunol 2008: 181: 5956-5962.
27. Knobler R, Barr M L, Couriel D R et al. J Am Acad Dermatol 2009: 61: 652-665.
28. Dani T, Knobler R. Front Biosci 2009: 14: 4769-4777.
29. Schmitt S, Johnson T S, Karakhanova S et al. Transplantation 2009: 88: 411-416.
30. Rao V, Saunes M, Jorstad S et al. Clin Immunol 2009: 133: 303-313.
31. Quaglino P, Comessatti A, Ponti R et al. Int J Immunopathol Pharmacol 2009: 22: 353-362.
32. Kusztal M, Koscielska-Kasprzak K, Gdowska W et al. Transplant Proc 2011: 43: 2938-2940.
33. Horina J H, Mullegger R R, Horn S et al. Lancet 1995: 346: 61.